This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Richardson, M A Articles by Rao, R N Search for Related Content PubMed PubMed Citation Articles by Richardson, M A Articles by Rao, R N

 Previous Article  |  Next Article 

J Bacteriol. 1990 July; 172(7): 3790-3798

research-article

Cloning of spiramycin biosynthetic genes and their use in constructing Streptomyces ambofaciens mutants defective in spiramycin biosynthesis.

Lilly Research Laboratories, Division of Eli Lilly and Company, Indianapolis, Indiana 46285.

ABSTRACT

Several cosmid clones from Streptomyces ambofaciens containing the spiramycin resistance gene srmB were introduced into S. fradiae PM73, a mutant defective in tylosin synthesis, resulting in tylosin synthesis. The DNA responsible for this complementation was localized to a 10.5-kilobase EcoRI fragment. A 32-kilobase DNA segment which included the srmB spiramycin resistance gene and DNA which complemented the defect in strain PM73 were mutagenized in vivo with Tn10 carrying the gene for Nmr (which is expressed in Streptomyces spp.) or in vitro by insertional mutagenesis with a drug resistance gene (Nmr) cassette. When these mutagenized DNA segments were crossed into the S. ambofaciens chromosome, three mutant classes blocked in spiramycin synthesis were obtained. One mutant accumulated two precursors of spiramycin, platenolide I and platenolide II. Two mutants, when cofermented with the platenolide-accumulating mutant, produced spiramycin. Tylactone supplementation of these two mutants resulted in the synthesis of a group of compounds exhibiting antibiotic activity. Two other mutants failed to coferment with any of the other mutants or to respond to tylactone supplementation.

This article has been cited by other articles:

• Karray, F., Darbon, E., Oestreicher, N., Dominguez, H., Tuphile, K., Gagnat, J., Blondelet-Rouault, M.-H., Gerbaud, C., Pernodet, J.-L. (2007). Organization of the biosynthetic gene cluster for the macrolide antibiotic spiramycin in Streptomyces ambofaciens. Microbiology 153: 4111-4122 [Abstract] [Full Text]  
• Choulet, F., Aigle, B., Gallois, A., Mangenot, S., Gerbaud, C., Truong, C., Francou, F.-X., Fourrier, C., Guerineau, M., Decaris, B., Barbe, V., Pernodet, J.-L., Leblond, P. (2006). Evolution of the Terminal Regions of the Streptomyces Linear Chromosome. Mol Biol Evol 23: 2361-2369 [Abstract] [Full Text]  
• Pang, X., Aigle, B., Girardet, J.-M., Mangenot, S., Pernodet, J.-L., Decaris, B., Leblond, P. (2004). Functional Angucycline-Like Antibiotic Gene Cluster in the Terminal Inverted Repeats of the Streptomyces ambofaciens Linear Chromosome. Antimicrob. Agents Chemother. 48: 575-588 [Abstract] [Full Text]  
• Schauner, C., Dary, A., Lebrihi, A., Leblond, P., Decaris, B., Germain, P. (1999). Modulation of Lipid Metabolism and Spiramycin Biosynthesis in Streptomyces ambofaciens Unstable Mutants. Appl. Environ. Microbiol. 65: 2730-2737 [Abstract] [Full Text]  
• Donadio, S, Staver, M., McAlpine, J., Swanson, S., Katz, L (1991). Modular organization of genes required for complex polyketide biosynthesis. Science 252: 675-679 [Abstract]